Theta Research
  • Console
  • Supply Chain
  • Stock ResearchPro
  • Event Outlook
θDecision Desk
  • DBDashboard55
  • POPortfolio
  • CACalendar
  • SCScreening
  • IMImpact
  • RERegime
  • TRTrack Record

Conclusions are published after independent cross-review.

WMWaste Management, Inc.
BuyConviction 4.8/10PW target $248.50+8.5%Rated Apr 15Full research page

Verdict

Waste Management is a compounding infrastructure monopoly disguised as a boring waste hauler. The company owns the largest permitted landfill network in North America (257 sites) — a finite, irreplaceable asset base that creates structural pricing power, route density advantages, and ~72% internalization rates. The Stericycle acquisition ($7.2B, Nov 2024) added a healthcare waste franchise, while $3B in sustainability investments (RNG + recycling automation) are building a second growth engine that will contribute ~$1B in adjusted EBITDA by 2027. With core price yield of 5-6%, 30%+ adjusted EBITDA margins, and a 14.5% dividend increase for 2026, WM is a rare asset: a defensive compounder with embedded optionality on renewable energy and circular economy trends.

ScenarioProb.TargetDriver
Bull25%$290.00Stericycle integration delivers $250M+ synergies ahead of schedule — healthcare margins converge to legacy WM levels
Base50%$252.00Core pricing sustains 5-6% yield with flat-to-positive volume — consistent with management 2026 guidance
Bear25%$200.00Macro slowdown reduces commercial/industrial waste volumes by 2-3% — construction and demolition debris declines

Change history

  • Apr 15View held

    Phase A foundation research

Watching

  • Q1 2026 earnings releaseApr 2870d ago
  • Q1 2026 earnings — core price yield, healthcare margin trajectory, RNG commissioningApr 2870d ago
  • EPA PFAS hazardous constituent listing target finalizationApr 3068d ago
  • EPA PFAS hazardous constituent listing — passive receiver liability resolutionApr 3068d ago
  • Stericycle ERP migration completion — normalizes healthcare operationsJun 307d ago
  • Q2 2026 earnings release (estimated)
Jul 29
in 22d
  • Q3 2026 earnings release (estimated)Oct 28in 113d
  • RNG facility commissioning — 6 new facilities in 2026, volume doublingDec 31in 177d
  • Q4 2026 / FY2026 earnings release (estimated)Jan 28, 2027in 205d
  • FCF inflection to ~$3.8B guided — validates capital return accelerationJan 28, 2027in 205d
  • Sustainability EBITDA ~$1B target validationDec 31, 2027in 542d
  • Core price yield drops below 4% for two consecutive quarters — pricing power erosion signal
  • Stericycle healthcare EBITDA margins remain below 20% through Q2 2027 — failed synergy realization
  • EPA enforcement actions specifically target WM landfills for PFAS remediation (not industry-wide framework)
  • OCC (old corrugated containers) price falls below $40/ton — wipes out recycling segment profitability
  • Free cash flow misses 2026 guidance of ~$3.8B by more than 15%
  • C&I waste volumes decline more than 3% YoY for two consecutive quarters — recession signal
  • Net debt/EBITDA increases above 3.5x — deleveraging stalls from Stericycle acquisition financing
  • Stericycle synergies exceed $250M — healthcare EBITDA margins converge to 25%+ by Q4 2026
  • RNG adjusted EBITDA contribution reaches $600M+ in 2026 — validates sustainability growth thesis
  • EPA PFAS framework includes passive receiver protections — clears WM's regulatory overhang
  • Core price yield sustains above 5.5% with volume growth above 0.5% — organic revenue growth 6%+
  • Free cash flow exceeds $4B in 2026 — supports accelerated buybacks beyond $3B authorization
  • Latest notes

    • Apr 15Deep Research: WM — Defensive Infrastructure Compounder
    • Apr 15Competitive Deep Dive — 2026-04-15

    Exposure

    1-hop
    Suppliers
    • CAT
    Customers

    None mapped.

    Options radar

    Concept — illustrative data
    • Jun 30Call$110.00Aug 211,200 ct$540K
    • Jun 30Call$105.00Jul 17800 ct$216K
    • Jun 29Put$95.00Aug 21600 ct$168K
    Unusual volume3.2x 20-day avg call volume
    IV shift30-day IV 41% → 48%

    Positioning skews toward near-term upside